OSIR
Barclays’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-82,690
| Closed | -$1.57M | – | 4660 |
|
|
2019
Q1 | $1.57M | Buy |
82,690
+47,652
| +136% | +$905K | ﹤0.01% | 1763 |
|
|
2018
Q4 | $473K | Buy |
35,038
+34,891
| +23,735% | +$471K | ﹤0.01% | 2289 |
|
|
2018
Q3 | $2K | Buy |
+147
| New | +$2K | ﹤0.01% | 4207 |
|
|
2017
Q1 | – | Sell |
-9,377
| Closed | -$45K | – | 4332 |
|
|
2016
Q4 | $45K | Buy |
9,377
+5,228
| +126% | +$25.1K | ﹤0.01% | 2876 |
|
|
2016
Q3 | $20K | Buy |
4,149
+2,290
| +123% | +$11K | ﹤0.01% | 3046 |
|
|
2016
Q2 | $9K | Sell |
1,859
-33,162
| -95% | -$161K | ﹤0.01% | 3035 |
|
|
2016
Q1 | $175K | Sell |
35,021
-506
| -1% | -$2.53K | ﹤0.01% | 2114 |
|
|
2015
Q4 | $356K | Buy |
35,527
+21,094
| +146% | +$211K | ﹤0.01% | 1818 |
|
|
2015
Q3 | $260K | Sell |
14,433
-6,548
| -31% | -$118K | ﹤0.01% | 2024 |
|
|
2015
Q2 | $399K | Buy |
20,981
+17,570
| +515% | +$334K | ﹤0.01% | 1844 |
|
|
2015
Q1 | $59K | Sell |
3,411
-7,258
| -68% | -$126K | ﹤0.01% | 2685 |
|
|
2014
Q4 | $160K | Sell |
10,669
-34,406
| -76% | -$516K | ﹤0.01% | 2464 |
|
|
2014
Q3 | $540K | Buy |
45,075
+28,748
| +176% | +$344K | ﹤0.01% | 1936 |
|
|
2014
Q2 | $245K | Sell |
16,327
-8,376
| -34% | -$126K | ﹤0.01% | 2307 |
|
|
2014
Q1 | $321K | Buy |
24,703
+3,230
| +15% | +$42K | ﹤0.01% | 2164 |
|
|
2013
Q4 | $343K | Sell |
21,473
-7,419
| -26% | -$119K | ﹤0.01% | 2329 |
|
|
2013
Q3 | $462K | Buy |
28,892
+6,416
| +29% | +$103K | ﹤0.01% | 2155 |
|
|
2013
Q2 | $227K | Buy |
+22,476
| New | +$227K | ﹤0.01% | 2620 |
|